About Maine Medical Partners - South Portland
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
National Cancer Institute (NCI)
28
Alliance for Clinical Trials in Oncology
6
ECOG-ACRIN Cancer Research Group
6
NRG Oncology
6
SWOG Cancer Research Network
6
Vertex Pharmaceuticals Incorporated
3
Relievant Medsystems, Inc.
2
ASTORA Women's Health
1
AstraZeneca
1
National Heart, Lung, and Blood Institute (NHLBI)
1
RTOG Foundation, Inc.
1
Clinical Trials at Maine Medical Partners - South Portland
During the past decade, Maine Medical Partners - South Portland conducted 54 clinical trials. In the 10-year time frame, 54 clinical trials started and 7 clinical trials were completed, i.e. on
average, 13% percent of trials that started reached the finish line to date. In the past 5 years, 21 clinical trials started and 4 clinical trials were completed. i.e. 19%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Radiation Therapy With Concomitant and Adjuvant Temozolomide Versus Radiation Therapy With Adjuvant PCV Chemotherapy in Patients With Anaplastic Glioma or Low Grade Glioma
2009-09-01
Recruiting
360
SMART Clinical Study: Surgical Multi-center Assessment of RF Ablation for the Treatment of Vertebrogenic Back Pain
2011-10-01
2016-03-01
Completed
225
S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer
2013-04-01
2030-01-01
Active, not recruiting
1,900
Olaparib Maintenance Monotherapy in Patients With BRCA Mutated Ovarian Cancer Following First Line Platinum Based Chemotherapy.
2013-08-26
2028-08-29
Active, not recruiting
450
Erlotinib Hydrochloride in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Completely Removed by Surgery (An ALCHEMIST Treatment Trial)
2014-08-18
2026-10-10
Active, not recruiting
450
Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)
2014-08-18
Recruiting
8,300
Dabrafenib and Trametinib in Treating Patients With Stage III-IV BRAF Mutant Melanoma That Cannot Be Removed by Surgery
2014-07-22
2023-12-31
Active, not recruiting
280
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Maine Medical Partners - South Portland" #1 sponsor was "National Cancer Institute (NCI)" with 28 trials, followed by "Alliance for Clinical Trials in Oncology" with 6 trials
sponsored, "ECOG-ACRIN Cancer Research Group" with 6 trials sponsored, "NRG Oncology" with 6 trials sponsored and "SWOG Cancer Research Network"
with 6 trials sponsored. Other sponsors include 6 different institutions and
companies that sponsored additional 13 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Maine Medical Partners - South Portland"
#1 collaborator was "National Cancer Institute (NCI)" with 26 trials as a collaborator, "NRG Oncology" with 5 trials as a collaborator, "Canadian Cancer Trials Group" with 4 trials as a collaborator, "Astellas Pharma Inc" with 1 trials as a collaborator and "Bayer" with 1 trials as a collaborator. Other collaborators include 5 different institutions and companies that were
collaborators in the rest 15 trials.
Clinical Trials Conditions at Maine Medical Partners - South Portland
According to Clinical.Site data, the most researched conditions in "Maine Medical Partners - South Portland" are
"Stage IV Lung Cancer AJCC v8" (7 trials), "Recurrent Lung Non-Small Cell Carcinoma" (5 trials), "Stage IVA Lung Cancer AJCC v8" (4 trials), "Stage IVB Lung Cancer AJCC v8" (4 trials) and "Cystic Fibrosis" (3 trials). Many other conditions were trialed in "Maine Medical Partners - South Portland" in a lesser frequency.
Clinical Trials Intervention Types at Maine Medical Partners - South Portland
Most popular intervention types in "Maine Medical Partners - South Portland" are "Drug" (51 trials), "Other" (37 trials), "Procedure" (26 trials), "Biological" (24 trials) and "Radiation" (18 trials). Other intervention types were less common.
The name of intervention was led by "Quality-of-Life Assessment" (22 trials), "Computed Tomography" (17 trials), "Questionnaire Administration" (17 trials), "Biospecimen Collection" (15 trials) and "Nivolumab" (12 trials). Other intervention names were less common.
Clinical Trials Genders at Maine Medical Partners - South Portland
The vast majority of trials in "Maine Medical Partners - South Portland" are
54 trials for "All" genders, 6 trials for "Male" genders and 3 trials for "Female" genders.
Clinical Trials Status at Maine Medical Partners - South Portland
Currently, there are NaN active trials in "Maine Medical Partners - South Portland".
undefined are not yet recruiting,
30 are recruiting,
23 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 6 completed trials in Maine Medical Partners - South Portland,
3 suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Maine Medical Partners - South Portland, 1 "Phase 1"
clinical trials were conducted, 24 "Phase 2" clinical
trials and 42 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 3 trials that are defined as “Not Applicable".
Departments of Maine Medical Partners - South Portland
Maine Medical Partners - South Portland has several departments that took part in Clinical trials: "Maine Cardiology Associates" - 6 trials, "Maine Medical Partners Pediatric Specialty Care" - 6 trials, "Maine Medical Center Pediatrics-Site Number:840064" - 3 trials, "Maine Nephrology Associates" - 2 trials
Departments List
Name
City
Trials